MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in SVRA — Savara Inc

CIK 1705339 CAUSEWAY BAY, K3

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$443,821

+$15,607 QoQ

Shares Held

81,286

+14.5% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 184 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,370,693 across 239 Biotechnology names. SVRA ranks #120 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc.	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$443,821	81,286	+14.5%	Shares	Defined	2026-05-15
2025-12-31	$428,214	71,014	+33.5%	Shares	Defined	2026-02-17
2025-09-30	$189,906	53,195	-23.8%	Shares	Defined	2025-11-14
2025-06-30	$159,246	69,845	-1.9%	Shares	Defined	2025-08-14
2025-03-31	$197,290	71,224	-1.3%	Shares	Defined	2025-05-15
2024-12-31	$221,481	72,144	+3.4%	Shares	Defined	2025-02-14
2024-09-30	$295,900	69,788	+37.7%	Shares	Defined	2024-11-14
2024-06-30	$204,171	50,663	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.